|
KIAA0652 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20459975327947E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.13870004933869E-09 |
| Normal-vs-Stage2 |
1.482350E-02 |
| Normal-vs-Stage3 |
8.13582534675561E-12 |
| Normal-vs-Stage4 |
7.77350406266919E-11 |
| Stage1-vs-Stage2 |
1.884290E-02 |
| Stage1-vs-Stage3 |
5.883900E-02 |
| Stage1-vs-Stage4 |
4.660800E-03 |
| Stage2-vs-Stage3 |
1.501070E-03 |
| Stage2-vs-Stage4 |
1.374410E-04 |
| Stage3-vs-Stage4 |
1.483790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20823359597944E-12 |
| Normal-vs-AfricanAmerican |
5.055200E-03 |
| Normal-vs-Asian |
3.35809999807424E-08 |
| Caucasian-vs-AfricanAmerican |
1.295770E-01 |
| Caucasian-vs-Asian |
8.731400E-01 |
| AfricanAmerican-vs-Asian |
2.464200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.04809999965394E-08 |
| Normal-vs-Female |
1.71439973328802E-10 |
| Male-vs-Female |
8.318400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.16839999897422E-08 |
| Normal-vs-Age(41-60Yrs) |
1.04990000027172E-08 |
| Normal-vs-Age(61-80Yrs) |
8.43699998753777E-09 |
| Normal-vs-Age(81-100Yrs) |
5.138500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.709200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.135000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.118000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.991000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.602800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.550000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.72615999999293E-05 |
| Classical-VS-Follicular |
5.136100E-03 |
| Classical-VS-Other |
7.751600E-02 |
| Classical-VS-Normal |
1.42750256060253E-11 |
| Tall-VS-Follicular |
3.24259999961996E-08 |
| Tall-VS-Other |
9.715000E-01 |
| Tall-VS-Normal |
2.87547763377916E-14 |
| Follicular-VS-Other |
2.935800E-02 |
| Follicular-VS-Normal |
5.401200E-03 |
| Other-VS-Normal |
7.89079999999887E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46050000005005E-06 |
| Normal-vs-N1 |
2.63122856836162E-14 |
| N0-vs-N1 |
1.84240000034031E-07 |
|
|
